• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Nepal Health Res Counc . Epidemiological and Spatial Distribution of COVID-19 Morbidity and Mortality in Nepal

tetano

Editor, Senior Moderator
J Nepal Health Res Counc


. 2024 Oct 3;22(2):252-257.
doi: 10.33314/jnhrc.v22i02.4775. Epidemiological and Spatial Distribution of COVID-19 Morbidity and Mortality in Nepal

Amod Kumar Poudyal[SUP] 1 [/SUP], Karuna Laxmi Shakya[SUP] 2 [/SUP], Vishnu Prasad Sapkota[SUP] 3 [/SUP], Rajan Paudel[SUP] 1 [/SUP], Salau Din Myia[SUP] 2 [/SUP], Pranil Man Singh Pradhan[SUP] 4 [/SUP], Dipak Prasad Upadhyaya[SUP] 1 [/SUP], Naresh Joshi[SUP] 1 [/SUP], Shital Shrestha[SUP] 2 [/SUP]



Affiliations
Abstract

Background: The Coronavirus (SARS-CoV-2) infection termed as COVID-19 was first detected in Wuhan, Hubei Province of China, in December 2019 and has been declared as a pandemic by the World Health Organization on January 30, 2020. The study aims to understand the time, place and person distribution of covid-19 morbidity, mortality of COVID-19 in Nepal.
Methods: The analysis produces the descriptive epidemiological features of COVID-19 pandemic in Nepal. The data was analysed to produce disaggregated case rate and case fatality rate across various time, place and personal characteristics aggregated at national and subnational level Results: The study found that the observed case rate was significantly higher among males compared to females. Similarly, case rate was the highest among males of 31-40 years and females of 51- 60 years. Case fatality rate increased with age group. Above the age of 41-50 years, case fatality rate was higher among males compared to females. We observed that case fatality rate was disproportionately concentrated among the poor districts in terms of GDP Conclusions: The observed case rate is significantly higher among males compared to females, however case fatality rate increased with age group. Case rate was found the highest in the Bagmati province followed by the Gandaki Province. However, case fatality rate was found the highest in hilly and mountain districts of Province 1, Gandaki and Karnali. Case fatality rate was disproportionately concentrated among the poor districts in terms of GDP.

Keywords: COVID19; morbidity; mortality; Nepal..

 
Back
Top Bottom